Home > News > Protiveris Received MIPS Award for Technology Optimization
April 1st, 2004
Protiveris Received MIPS Award for Technology Optimization
Abstract:
Protiveris Inc., a bio- nanotechnology company commercializing bioMEMS technologies to facilitate protein research and the discovery of new pharmaceuticals, today announced that it is a recipient of a $116,000 award from the Maryland Industrial Partnerships (MIPS) program. This award is to be used for the optimization of microfluidic sample delivery system in the VeriScan(TM) 3000 -- the Company's patent pending biosensor system for advanced biological and chemical detection.
Source:
Protiveris
Bookmark:
Investments/IPO's/Splits
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013